Dr. Williamson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1216 W 71 Ter
Kansas City, MO 64114
Education & Training
- University of Kansas School of MedicineFellowship, Hematology and Medical Oncology, 1984 - 1986
- University of Oklahoma School of Community Medicine (Tulsa)Residency, Internal Medicine, 1979 - 1982
- University of Kansas School of MedicineClass of 1979
- Kansas Newman CollegeB.S., 1972 - 1976
Certifications & Licensure
- KS State Medical License 1982 - 2025
- MO State Medical License 1984 - 2025
- OK State Medical License 1980 - 1984
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- University of Kansas Top Doc Award Kansas University Hospital, 2005
- Best Doctors in America 2005
- Join now to see all
Clinical Trials
- Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer Start of enrollment: 1998 Oct 01
- Combination Chemotherapy With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer Start of enrollment: 2000 Nov 01
- S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus Start of enrollment: 2001 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 34 citationsClinical and biomarker results from phase I/II study of PI3K inhibitor alpelisib plus nab-paclitaxel in HER2-negative metastatic breast cancerPriyanka Sharma, Vandana G Abramson, Anne O'Dea, Lauren Nye, Ingrid A. Mayer
Clinical Cancer Research. 2021-02-18 - 47 citationsA phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignanciesStephen K. Williamson, Gary Johnson, Holly Maulhardt, Kathleen M. Moore, D.S. McMeekin
Cancer Chemotherapy and Pharmacology. 2015-04-23 - 85 citationsHigh Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa studyKishore Polireddy, Ruochen Dong, Gregory A. Reed, Jun Yu, Ping Chen
Scientific Reports. 2017-12-07
Journal Articles
- Capecitabine versus 5-fluorouracil in colorectal cancer: where are we now?Chintala L, Vaka S, Baranda J, Williamson SK, Oncol Rev, 1/1/2011
- Chemotherapy in Head and Neck Cancer: Clinical Predictors of Tolerance and OutcomesKubicek GJ, Kimler BF, Wang F, Reddy EK, Girod DA, Williamson SK, Am J Clin Oncol, 1/24/2010
- Treatment of Gastric Cancer (Letter to editor)Singh J, Williamson SK, Malani AK, NEJM, 1/1/2006
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A Phase I Trial of Irinotecan (Iri) and Buparlisib (B) in Previously Treated Patients (PTS) with Metastatic Colorectal Cancer (mCRC).J.C. Baranda, G. Reed, S. Williamson, M. Stoltz, R. Perez, C. Mackay, R. Madan, J.Scott, A, Meeting 2014 European Society for Medical Oncology, 2014 European Society for Medical Oncology, 1/26/2014
- Phase I clinical trial of the intraperitoneal (IP) administration of a novel nanoparticle formulation of paclitaxel (NTX).Williamson SK, Wick J, Chapman JA, Johnson G, Reed G, Schulz TK, Smith H, Weir S, Decedue CJ, Howell, J and Roby, K, Annual Meeting of the American Society of Clinical Oncology, Chicago, IL, 1/31/2013
- Docetaxel followed by temsirolimus suppresses mTOR pathway and can overcome PI3K / AKT over-activation mechanism of resistance in lung cancer cell line.Huang CH, Godachova A, Misra J, Holton E, Beaudoin C, Williamson, SK, Van Veldhuizen PJ, Annual Meeting of the American Association for Cancer Research, Washington, DC, 1/6/2013
- Join now to see all
Lectures
- Update on Hepatocelllular Carcinoma, an Oncologist's PerspectiveUniversity of Kansas Medical Center, Kansas City, KS - 1/1/2011
- Update on AJCC Staging and use of EMR for stagingUniversity of Kansas Medical Center, Kansas City, KS - 1/1/2010
- Best of Oncology 2008University of Kansas Medical Center, Kansas City, KS - 1/1/2008
- Join now to see all
Press Mentions
- Thermo Fisher Scientific Q2 Revenues Soar 10 Percent, Driven by Pandemic DemandJuly 22nd, 2020
Professional Memberships
- Member
External Links
- KU Cancer Centerhttp://www.kumc.edu/iami/partnerships-and-collaborations/university-of-kansas-cancer-center.html
- KU Med Linkhttp://www.kumc.edu/school-of-medicine/internal-medicine/medical-oncology/faculty/stephen-williamson.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: